Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 351-359
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.351
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.351
PAC group | PAM group | Sequential | Concomitant | P value | |
(n = 170) | (n = 170) | (n = 170) | (n = 170) | ||
Age, yr | 55.6 ± 13.6 | 57.4 ± 12.8 | 58.3 ± 12.3 | 55.8 ± 12.6 | 0.1031 |
Gender | 0.0602 | ||||
Male | 102 (60.0) | 107 (62.9) | 110 (64.7) | 106 (62.4) | |
Female | 68 (40.0) | 63 (37.1) | 60 (35.3) | 64 (37.7) | |
Diagnosis | 0.5532 | ||||
Gastric ulcer | 81 (47.7) | 77 (45.3) | 86 (50.6) | 78 (45.9) | |
Duodenal ulcer | 36 (21.2) | 28 (16.5) | 32 (18.8) | 27 (15.9) | |
Gastritis | 53 (31.2) | 65 (38.2) | 52 (30.6) | 65 (38.2) |
-
Citation: Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY, Chung WC, Kim BW, Kim SS. Concomitant therapy achieved the best eradication rate for
Helicobacter pylori among various treatment strategies. World J Gastroenterol 2015; 21(1): 351-359 - URL: https://www.wjgnet.com/1007-9327/full/v21/i1/351.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.351